Skip to main content
Home
News
Live
Companies
Pricing
About Us
Language
...
Sign In
Register
#Axsome Therapeutics News | Tervion
Back to News
Tag: #Axsome Therapeutics
1 articles
Title
Company
Published
FDA approves Auvelity for agitation associated with dementia due to Alzheimer’s disease
#FDA approval
#Alzheimer’s disease
#Axsome Therapeutics
#Auvelity
#Neuropsychiatry
Tervion
May 1, 2026
